Versed News and Research

RSS

Versed is a drug used to treat anxiety and tension and to relax muscles. It is also being studied in the treatment of nausea and vomiting caused by some cancer treatments. It is a type of benzodiazepine. Also called midazolam and midazolam hydrochloride.

JumpStart Ventures invests $250,000 in SPR Therapeutics

JumpStart Ventures, a nonprofit that invests in and partners with innovative, early-stage companies in Northeast Ohio, announced an investment commitment of $250,000 in SPR Therapeutics.

27 Apr 2011

QHR signs agreement to acquire EMIS assets

QHR Technologies Inc. today announced that the Company has signed an Asset Purchase Agreement ("APA") to acquire the assets of EMIS Inc. a 100% subsidiary of Egton Medical Information Systems Limited based in Leeds, UK and part of EMIS Group plc.

27 Apr 2011

Ashford University introduces Bachelor of Arts in Health Education degree

Ashford University, an academic institution owned by Bridgepoint Education, has just introduced its Bachelor of Arts in Health Education degree. This program is positioned to support students seeking employment in the ever-expanding health care industry.

18 Feb 2011

Pediatric physicians present 12 research abstracts, posters at Cardiology 2011

Pediatric cardiology researchers and clinicians gather this week in Scottsdale, Ariz. for Cardiology 2011, the 15th Annual Update on Pediatric and Congenital Cardiovascular Disease, sponsored by The Children's Hospital of Philadelphia. Original research from more than 30 cardiac programs in the U.S. and abroad is being presented throughout the meeting.

7 Feb 2011

Key Equipment Finance and Hitachi Medical Systems America enter new partnership

Key Equipment Finance, one of the nation's largest bank-held equipment finance companies and an affiliate of KeyCorp today announced that the company has entered into an exclusive, long term, program agreement with Hitachi Medical Systems America. Hitachi Medical Systems America is the U.S. distributor of Hitachi Medical Corporation's diagnostic imaging products.

10 Jan 2011

AZ-TMJ develops effective treatment for migraine headaches

AZ-TMJ is once again leading the way in innovative and effective treatments for severe cases of Temporomandibular Joint Disorders or TMD. AZ-TMJ has developed a variety of highly effective treatments to greatly reduce the frequency and severity of migraine headaches for a large percentage of sufferers. Approximately 16% to 17% of the population suffers from migraine headaches, which often have a debilitating effect on suffers' daily lives.

27 Oct 2010

BUSM to create Center for Health Insurance Reform, Cardiovascular Outcomes and Disparities

Boston Medical Center (BMC) has been awarded a four year, $5.7 million grant from the National Heart, Lung and Blood Institute (NHLBI) for investigators from Boston University School of Medicine (BUSM) to create the Center for Health Insurance Reform, Cardiovascular Outcomes and Disparities.

1 Oct 2010

Johns Hopkins offers sources who can answer queries on prostrate cancer

September 19-25 is National Prostate Cancer Awareness Week. If you are planning a story on prostate cancer, a disease that's diagnosed in more than 200,000 American men each year, please consider calling on experts from the Johns Hopkins Brady Urological Institute.

16 Sep 2010

Rural development in Australia

Rural health services in Australia are in bad shape. Cancer mortality rates are higher, waiting lines for doctor visits are longer, and budget share of Medicare spending is lower. Despite this the issue has not drawn the attention of the election campaign.

23 Aug 2010

Ill effects of methamphetamine

On the street it's known as meth, speed, ice, chalk, crank, fire, glass or crystal. Methamphetamine is a highly addictive drug that wreaks havoc on the entire body, including the user's oral health. Approximately 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.

17 Aug 2010

Endologix responds to Bard Peripheral Vascular's patent infringement lawsuit

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, responded to the Bard Peripheral Vascular, Inc. lawsuit filed against Endologix in the United States District Court of Arizona. The Bard Peripheral lawsuit alleges that Endologix's proprietary high density ePTFE graft material, which is used for the Powerlink® System, infringes on Bard Peripheral's "Prosthetic Vascular Graft" patent (U.S. Patent No. 6,436,135).

12 Aug 2010

Failed ACL surgeries are more common than previously thought

Nick Van Erp, active in soccer since elementary school and lacrosse since junior high, tore the anterior cruciate ligament in his knee during a spring lacrosse game his freshman year of high school. His injury, caused by stepping into a pothole and hyper-extending his knee, required surgical repair, ending his season prematurely and the remainder of his high school sports career.

29 Jun 2010

Compliance Jumpstart introduces healthcare compliance program

Compliance Jumpstart, a privately held compliance consulting firm assisting medical companies with implementing healthcare compliance programs addressing areas such as the Anti-Kickback Statute and the Stark Law, announced the introduction of their healthcare compliance program.

23 Jun 2010

McDermott's Health Industry Advisory Practice Group recognized as Health Team of the Year

McDermott Will & Emery is pleased to announce the Firm's Health Industry Advisory Practice Group was honored as the "Health Team of the Year" during the Chambers USA Awards in New York on June 10, 2010. This is the first time an award in this category has been given on a national basis by Chambers, and McDermott was selected over four other finalist firms.

14 Jun 2010

International experts discuss threats posed by ticks and fleas

As experts from around the world met in New York this week they discussed the need for greater understanding of the threat posed by ticks, fleas and sand flies. Leading scientists called on veterinarians and dog-owners around the world to take action to protect dogs and humans from potentially lethal diseases.

16 Apr 2010

Stem cell-enriched autologous fat for breast augmentation

Whereas US and European medical centers are still beginners in breast augmentation with stem cell-enriched autologous fat, Viennese New Cosmetic Surgery and anti-aging expert DDr. Karl-Georg Heinrich is well-versed in this revolutionary method. In his Clinic DDr. Heinrich, he has been successfully offering breast augmentations with autologous stem cells to a broad public since early 2007.

7 Apr 2010

Growing problem of prescription drug abuse

Prescription painkiller abuse is a rapidly growing and widespread problem, recently coming into full view due to high profile stories and tragic celebrity deaths.

3 Apr 2010

Mach One completes “Definitive Agreement” for merger and acquisition of White Hat Brands

Mach One Corporation, a global wellness solutions company, today announced the completion of a “Definitive Agreement” for the terms and conditions for the merger and acquisition of White Hat Brands, LLC, producers of a variety of all natural, multi-vitamin-fortified juice beverages for children under the brand name Dog On It!™.

23 Mar 2010

Legacy Biotechnologies, Phillips Sales and Marketing reach agreement to distribute Reme-Flu remedy

Nuvilex, Inc., announces today that Legacy Biotechnologies, Inc., its joint venture partner in Reme-Flu™ homeopathic flu remedy, has reached an agreement with Phillips Sales and Marketing to begin the national sales and marketing campaign for retail distribution of Reme-Flu™.

22 Mar 2010

Legacy Biotechnologies commences production of Reme-Flu

Nuvilex, Inc., announces today that Legacy Biotechnologies, Inc., its joint venture partner in Reme-Flu™, has commenced production of Reme-Flu™ and expects it to be ready for consumer purchase within the next 30 days. Reme-Flu™ is Legacy Biotechnologies’ unique 2-part homeopathic flu remedy designed to help treat symptoms of the flu. Initially, Reme-Flu™ will be offered on the top-rated website, www.nutralegacy.com.

18 Mar 2010